期刊文献+

细胞因子不同的组合方式对人骨髓Ac133+细胞增殖的影响

Research for the Influence of Different Cell Factor Combinations to the Human Bone Marrow AC133+ Cells Ex Vivo
下载PDF
导出
摘要 目的探讨细胞因子不同的组合方式对人骨髓AC133+富集细胞体外扩增的影响。方法常规富集AC133+细胞,按照细胞因子不同的组合方式分为2组,在不同细胞因子组合刺激下进行体外对照培养,观察AC133+富集细胞的扩增情况;应用甲基纤维素半固体培养法,观察不同组别培养7天、14天、21天AC133+富集细胞的集落形成情况及细胞凋亡率。结果观察组的细胞因子组合扩增倍数、集落形成数目于培养7天后明显高于对照组,P<0.01;细胞凋亡率于培养21天后低于对照组,P<0.05。结论观察组的细胞因子组合方式既维持了干细胞自我更新的能力又在很大程度上扩增了造血祖细胞,显示了充分的优越性。 Objective To explore the influence of different cell factor combinations on the human bone marrow AC133 + cells ex vivo. Methods The MiniMACS was used to gather AC133 + cells. There are 2 groups: the trai and control group. Through the ex vivo comparison of cultivation under different cell factor combination stimulation, expansion of AC133 + selection cells is observed. Observe the clone formation of the AC133 + ells using Half - solid Methyl cellulose under different cell factor stimulation ( in 7 d, 14 d,21 d. ) and Observe the rate of cells apoptosis. Results The number the expansion folds and clones of AC133 + from trial group were significantly more than those from control in 7 d, 14 d ,21 d ( P 〈 0.01 ). The rate of cells apoptosis from trial group is lower than those from control in 21 d and 28 d, P 〈 0.05. Conclusion Through the 4-week short-term cultivation, Cell factor combination from the trail is a well choice combination for ex vivo expansion, the combination keeps the ability of hematopoietic stem cell s' ability:self duplication and supper suffer hematopoietic progenitor cells.
出处 《实用癌症杂志》 2007年第5期448-450,共3页 The Practical Journal of Cancer
关键词 人骨髓造血干细胞 AC133+细胞 细胞因子 扩增 凋亡 Human bone marrow hematopoietic stem cell AC133 + cell Cell factor Expansion Apoptosis
  • 相关文献

参考文献10

  • 1Cedar SH.The function of stem cells and their future roles in healthcare[J].Br J Nurs,2006,15(2):104.
  • 2Akashi K.Stem cell system and regenerative medicine[J].Fukuoka Igaku Zasshi,2004,95(12):314.
  • 3Plet PA,Abonour R,Frankovitz SM,et al.Impact of modeled microgravity on migration,differentiation,and cell cycle control of primitive human hematopoietic progenitor cells[J].Exp Hematol,2004,32 (8):773.
  • 4Matsumoto K,Yasui K,Yamashita N,et al.In vitro proliferation potential of AC133 positive cells in peripheral blood[J].Stem Cells,2000,18 (3):196.
  • 5Pasino M,Lanza T,Marotta F.Flow cytometric and functional characterization of AC133 + cells from human umbilical cord blood[J].Br J Haematol,2000,108 (4):793.
  • 6Kasakura S.Cytokines and hematology[J].Int J Hematol,2001,74(1):1.
  • 7Mijazaki IL,Karo T,Thrombopoietin.Biology and clinical potential[J].Ini Hematol,1999,70(4):216.
  • 8Wilson A,Trumpp A.Bone-marrow haematopoietic stem cell niches[J].Nat Rev Immunol,2006,6(2):93.
  • 9Encabo A,Solves P,Mateu E,et al.Selective generation of different dendritic cell precursors from CD34 + cells by interleukin-6 and interleukin-3[J].Stem Cells,2004,22(5):725
  • 10Kobari L,Giarratana MC,Poloni A,et al.Flt 3 ligand,MGDF,Epo and G-CSF enhance ex vivo expansion of hematopoietic cell compartments in the presence of SCF,IL-3 and IL-6[J].Bone Marrow Transplant,1998,21 (8):759.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部